| 1 |
Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management [J]. Lancet Neurol, 2019, 18(4): 394-405.
|
| 2 |
Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults [J]. Circulation, 2017, 135(8): 759-771.
|
| 3 |
中国卒中防治报告编写组. 《中国脑卒中防治报告2019》概要 [J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
|
| 4 |
Gąsecki D, Kwarciany M, Kowalczyk K, et al. Blood pressure management in acute ischemic stroke [J]. Curr Hypertens Repo, 2021, 23(1): 3.
|
| 5 |
Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States [J]. Am J Emerg Med, 2007, 25(1): 32-38.
|
| 6 |
Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) [J]. Stroke, 2009, 40(7): 2442-2449.
|
| 7 |
Fischer U, Cooney MT, Bull LM, et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study [J]. Lancet Neurol, 2014, 13(4): 374-384.
|
| 8 |
Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls [J]. Stroke, 1986, 17(5): 861-864.
|
| 9 |
Jiang B, Churilov L, Kanesan L, et al. Blood pressure may be associated with arterial collateralization in anterior circulation ischemic stroke before acute reperfusion therapy [J]. J Stroke, 2017, 19(2): 222-228.
|
| 10 |
Christoforidis GA, Saadat N, Kontzialis M, et al. Predictors for the extent of pial collateral recruitment in acute ischemic stroke [J]. Neuroradiol, 2020, 33(2): 98-104.
|
| 11 |
Toyoda K, Okada Y, Jinnouchi J, et al. High blood pressure in acute ischemic stroke and underlying disorders [J]. Cerebrovasc Dis, 2006, 22(5-6): 355-361.
|
| 12 |
Wohlfahrt P, Krajcoviechova A, Jozifova M, et al. Low blood pressure during the acute period of ischemic stroke is associated with decreased survival [J]. J Hypertens, 2015, 33(2): 339-345.
|
| 13 |
Fischer U, Mattle HP. Blood pressure in acute stroke: still no answer for management [J]. Stroke, 2017, 48(7): 1717-1719.
|
| 14 |
Koton S, Eizenberg Y, Tanne D, et al. Trends in admission blood pressure and stroke outcome in patients with acute stroke and transient ischemic attack in a National Acute Stroke Registry [J]. J Hypertens, 2016, 34(2): 316-322.
|
| 15 |
Sripal B, Lee S, Eric E S, et al. Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke [J]. Eur Heart J, 2017, 38(37): 2827-2835.
|
| 16 |
Robinson TG, Potter JF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial [J]. Lancet Neurol, 2010, 9(8): 767-775.
|
| 17 |
Ishitsuka K, Kamouchi M, Hata J, et al. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes. Fukuoka Stroke Registry [J]. Hypertension. 2014, 63(1): 54-60.
|
| 18 |
Eivind B, Geoffrey C, Richard I, et al. Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke [J]. Stroke, 2015, 46(12): 3362-33629.
|
| 19 |
Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial [J]. Lancet Neurol, 2009, 8(1): 48-56.
|
| 20 |
He J, Zhang Y, Xu T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial [J]. JAMA, 2014, 311(5): 479-489.
|
| 21 |
The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial [J]. Lancet, 2015, 385(9968): 617-628.
|
| 22 |
Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial [J]. Lancet, 2011, 377(9767): 741-750.
|
| 23 |
Hornslien AG, Sandset EC, Igland J, et al. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST) [J]. Int J Stroke, 2015, 10(6): 830-835.
|
| 24 |
Wang H, Tang Y, Rong X, et al. Effects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysis [J]. PLoS One, 2014, 9(5): e97917.
|
| 25 |
Lee M, Ovbiagele B, Hong KS, et al. Effect of blood pressure lowering in early ischemic stroke: meta-analysis [J]. Stroke, 2015, 46(7):1883-1889.
|
| 26 |
Maya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score [J]. Stroke, 2012, 43(6): 1524-1531.
|
| 27 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
| 28 |
William P, Alejandro R, Teri A, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Associatio [J]. Stroke, 2019, 50(12): e344-e418.
|
| 29 |
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke [J]. N Engl J Med, 1995, 33(24): 1581-1587.
|
| 30 |
Anderson CS, Huang Y, Lindley RI, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial [J]. Lancet, 2019, 393(10174): 877-888.
|
| 31 |
Malhotra K, Ahmed N, Filippatou A, et al. Association of elevated blood pressure levels with outcomes in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis [J]. J Stroke, 2019, 21(1): 78-90.
|
| 32 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性脑卒中早期血管内介入诊疗指南2018 [J]. 中华神经科杂志, 2018, 51(9): 683-691.
|
| 33 |
Maïer B, Delvoye F, Labreuche J, et al. Impact of blood pressure after successful endovascular therapy for anterior acute ischemic stroke: a systematic review [J]. Front Neurol, 2020, 11: 573382.
|
| 34 |
Marius M, Charith C, Matteo B, et al. Blood pressure after endovascular thrombectomy: modeling for outcomes based on recanalization status [J]. Stroke, 2020, 51(2): 519-525.
|
| 35 |
Mulder MJHL, Ergezen S, Lingsma HF, et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands) [J]. Stroke, 2017, 48(7): 1869-1876.
|
| 36 |
Mikael M, Sebastien R, Bertrand L, et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial [J]. Lancet Neurol, 2021, 20(4): 265-274.
|
| 37 |
Hong L, Cheng X, Lin L, et al. The blood pressure paradox in acute ischemic stroke [J]. Ann Neurol, 2019, 85(3): 331-339.
|